Skip to main content

Advertisement

Table 2 ECD, CV, Hex and CCT values of injected and uninjected eyes before intravitreal injection and follow-up visits

From: Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients

  Before injection 1st month 3rd month p value*
CD Injected eyes 2211.7 ± 370.6 2207.1 ± 351.9 2163.8 ± 357.7ab 0.018
Uninjected eyes 2219.8 ± 263.2 2265.9 ± 254.2 2102.8 ± 551.9 0.179
CV Injected eyes 37.86 ± 5.55 40.14 ± 6.47 40.05 ± 5.22 0.511
Uninjected eyes 40.70 ± 8.46 41.35 ± 5.85 41.94 ± 9.22 0.842
Hex Injected eyes 54.86 ± 6.84 55.81 ± 7.32 56.63 ± 8.25 0.481
Uninjected eyes 53.70 ± 8.55 53.95 ± 7.52 53.72 ± 8.92 0.879
CCT Injected eyes 567.5 ± 43.0 564.1 ± 43.9 556.5 ± 44.3 0.810
Uninjected eyes 556.9 ± 35.2 558.8 ± 39.7 563.3 ± 41.2 0.104
  1. *Friedman Test, aPost-hoc: Statistical difference detected before intravitreal injection and third month (p = 0.013), bPost-hoc: Statistical difference detected between first and third month (p = 0.009), ECD Endothelial cell density, CV Coefficient of variation of cell size, HEX Percentage of hexogonality and CCT Central corneal thickness by corneal specular microscopy